Pharmafile Logo
Pharmafocus logo
Advanced Search

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026
Ear Nose & throat

Sandoz has launched its azelastine and fluticasone fixed-dose-combination (FDC) nasal spray in Germany and Switzerland. In Germany the FDC over …

News

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026
Oncology

The Japan Pharmaceuticals and Medical Devices Agency (PMDA) has accepted the updated prescribing information for Daiichi Sankyo’s Enhertu (trastuzumab), a …

News

Trelleborg to take part in Medtec Japan 2026

April 8, 2026
Manufacturing and Production

Trelleborg Medical Solutions will showcase its latest engineered polymer solutions for demanding medical, biotech and pharmaceutical applications at Medtec Japan …

News

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026
Research and Development

Kainova Therapeutics has announced that the first patient in the European expansion of its DOMISOL phase I/II clinical trial evaluating …

News
drug-trials

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026
Research and Development

Eisai is to begin enrolling participants in its phase 2 study, Study 202, in patients with narcolepsy. The company registered …

News

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026
Faron Pharmaceuticals

Faron Pharmaceuticals, a clinical-stage biopharmaceutical company, has appointed Heikki Jouttijärvi as Chief Technical Officer (CTO). Jouttijärvi brings decades of experience …

Appointment

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026
Conferencing, Events & Incentives Cambridge, Cambridge Wide Open Week, London, Oxford

Cambridge Wide Open Week (CWOW) returns from 11-19 June 2026, sharing the spirit and buzz of the week-long, interactive festival …

News

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026
Doccla

Doccla, an AI-powered Proactive Care company, has appointed Michael Macdonnell as Chief Strategy & Growth Officer, and Deputy CEO. As …

Appointment

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026
Market & Product Development AI, Bramacare, eating disorders

Bramacare has launched an AI-enabled platform designed to aid eating disorder and rehabilitation services, the first of its kind in …

News

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026
Doccla

Doccla, an AI-powered Proactive Care company, has appointed Jonathan Serjeant as Chief Medical Officer (CMO). Serjeant brings 25 years of …

Appointment

SAH Diagnostics opens new diagnostics centre in Bristol

March 30, 2026
Health check service Bristol, Bristol Community Diagnostics Hub, SAH Diagnostics

SAH Diagnostics has opened a new privately run diagnostics centre in Bradley Stoke, Bristol, aiming to speed up cancer treatments …

News

Abselion appoints Dale Gordon as Chair

March 30, 2026
Abselion

Abselion has appointed Dale Gordon as Chair of the Board of Directors. Bringing over 30 years of experience to the …

Appointment

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026
Patient Awareness Programmes Bowel Cancer Awareness Month, Stage4You, mental health

Stage4You, a campaign funded and developed by Takeda UK and supported by Bowel Cancer UK, is encouraging patients with stage …

Feature

Scotland starts newborn screening for SMA

March 26, 2026
Novartis, Scotland, spinal muscular atrophy (SMA)

As part of a two-year evaluation funded by the Scottish government and Novartis, Scotland will screen newborn babies for Spinal …

News

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026
Secarna Pharmaceuticals

Secarna Pharmaceuticals has appointed Jens Holstein and Richard Mark Engelhard to its new Advisory Board. As part of the board, …

Appointment

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026
Research and Development AI, NVIDIA, Roche

Roche has expanded its global AI infrastructure with a NVIDIA AI factory, adding 2,176 high-performance graphics processing units (GPUs) across …

News

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026
ReproNovo

ReproNovo has appointed Mark Altmeyer as Chairman of the Board of Directors. Bringing over 35 years of experience to the …

Appointment

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026
Research and Development EndoCyclic Therapeutics, FDA, endometriosis

EndoCyclic Therapeutics’ Investigational New Drug (IND) application for its lead programme, ENDO-205, has been approved by the US FDA. With …

News

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026
Mestag Therapeutics

Mestag has appointed Lindsey Rolfe as Chief Medical Officer (CMO) and Pascal Merchiers as Chief Development Officer (CDO). Bringing over …

Appointment

Outrun Therapeutics announces its lead programme for HPV positive cancer

March 23, 2026
Research and Development HPV, Oncology, Outrun Therapeutics

Outrun Therapeutics has selected an E6AP inhibitor strategy as its lead programme for treating HPV positive head and neck cancer. …

News

IsomAb appoints Philip Brainin as CEO

March 19, 2026
IsomAb

IsomAb has appointed Dr Philip Brainin as CEO and member of the Board of Directors. In this new role, Dr …

Appointment
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026